Jump to content

3,4-Methylenedioxy-N-methylphentermine

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by IznoRepeat (talk | contribs) at 14:45, 30 July 2020 (References: remove template per TFD; gen fixes). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

3,4-Methylenedioxy-N-methylphentermine
Names
IUPAC name
1-(1,3-Benzodioxol-5-yl)-N,2-dimethylpropan-2-amine
Identifiers
3D model (JSmol)
ChEMBL
ChemSpider
  • InChI=1S/C12H17NO2/c1-12(2,13-3)7-9-4-5-10-11(6-9)15-8-14-10/h4-6,13H,7-8H2,1-3H3
    Key: CRFWCCGPRXKZSM-UHFFFAOYSA-N
  • CC(C)(NC)Cc1ccc2OCOc2c1
Properties
C12H17NO2
Molar mass 207.273 g·mol−1
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).

3,4-Methylenedioxy-N-methylphentermine (MDMP or 3,4-methylenedioxy-α,α,N-trimethylphenethylamine) is a lesser-known psychedelic drug. MDMP was first synthesized by Alexander Shulgin. In his book PiHKAL, the minimum dosage is listed as 110 mg, and the duration is listed as approximately 6 hours.[1] MDMP produces few to no effects, and is slightly similar to MDMA. Very little data exists about the pharmacological properties, metabolism, and toxicity of MDMP.

Legality

United Kingdom

This substance is a Class A drug in the Drugs controlled by the UK Misuse of Drugs Act.[2]

See also

References

  1. ^ MDMP entry in PiHKAL
  2. ^ "UK Misuse of Drugs act 2001 Amendment summary". Isomer Design. Retrieved 12 March 2014.